🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Exposure to Organochlorine Pollutants and Impact on Development in the Peripubertal Age in Guadeloupe

Recruitingn/aAges 16 Years - 22 YearsAllCentre Hospitalier Universitaire de la Guadeloupe
NCT06653660 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

In the context of environmental pollution of the French West Indies by chlordecone and questions about health consequences, monitoring at the peripubertal age of children born alive in the TIMOUN cohort is justified in several respects: - existence of an already established mother-child cohort whose live-born children will reach peripubertal ages during the period 2020-2022; - opportunity to verify hypotheses put forward on the basis of toxicological data acquired in laboratory animals and the hormonal characteristics of chlordecone (endocrine disruptor); - strong societal demand for such research to be carried out because of concerns about the sensitivity of children and adolescents to the effects of environmental xenobiotics, in particular on sexual development and the age of puberty; - recommendation of the Scientific Council Chlordecone Inserm - InVS; specific action of the National

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Be born to a mother whose pregnancy was included in the Timoun cohort (2004 - 2007) and whose parents agreed to be contacted later. * Residing in Guadeloupe at the peripubertal age * Affiliation to a social security scheme * Agreement to participate in the study and informed consent signed by the minor * Study participation agreement and informed consent signed by the parents Exclusion Criteria: * Refusal to participate in the research
💊

What it tests

  • Clinical examination
📍

Where

1 site
CHU of Guadeloupe
Pointe-à-Pitre, Guadeloupe
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy